Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease

Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease

Item
http://www.wikidata.org/entity/Q28277871
β-Caryophyllene/Hydroxypropyl-β-Cyclodextrin Inclusion Complex Improves Cognitive Deficits in Rats with Vascular Dementia through the Cannabinoid Receptor Type 2 -Mediated Pathway.Endocannabinoid system in neurodegenerative disorders.Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.Neurochemical and Behavior Deficits in Rats with Iron and Rotenone Co-treatment: Role of Redox Imbalance and Neuroprotection by Biochanin A.Neuroprotective activity of cannabinoid receptor-2 against oxidative stress and apoptosis in rat pups having experimentally-induced congenital hypothyroidism.Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K(+) Channel/p38-MAPK Signalling Pathway.Acute administration of beta-caryophyllene prevents endocannabinoid system activation during transient common carotid artery occlusion and reperfusion.β-Caryophyllene Pretreatment Alleviates Focal Cerebral Ischemia-Reperfusion Injury by Activating PI3K/Akt Signaling Pathway.Rapid Monitoring of Pharmacological Volatiles of Night-Flowering Evening-Primrose According to Flower Opening or Closing by Fast Gas Chromatography/Surface Acoustic Wave Sensor (Electronic zNose).Involvement of c-Abl Kinase in Microglial Activation of NLRP3 Inflammasome and Impairment in Autolysosomal System.The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension
P2860

Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease

Item
http://www.wikidata.org/entity/Q28277871
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@ast
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@en
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@nl
type
label
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@ast
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@en
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@nl
prefLabel
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@ast
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@en
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P478
P577
P698
P921
P932
P3181
P356
P1433
P1476
Cannabinoid Type 2 (CB2) Recep ...... e Model of Parkinson's Disease
@en
P2093
P2860
P304
P31
P3181
P356
P407
P478
P577
P698
P921
P932